Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
{{output}}
Background: A reliable preclinical model of patient-derived organoids (PDOs) was developed in a case study of a 69-year-old woman diagnosed with breast cancer (BC) to investigate the tumour evolution before and after neoadjuvant ... ...
